What Is Alpha-Lipoic Acid?
Alpha-lipoic acid (ALA) is a naturally occurring sulphur-containing compound that functions as a cofactor for mitochondrial enzyme complexes (pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase) and as a powerful antioxidant. Unlike most antioxidants which work in either water-soluble or fat-soluble compartments, ALA is active in both—earning it the label "universal antioxidant."
ALA exists in two forms: the natural R-ALA (biologically active) and the synthetic S-ALA. Most inexpensive supplements contain racemic ALA (50:50 mixture). R-ALA is 2–4× more bioavailable and has superior mitochondrial targeting.
Mechanisms
- Antioxidant network: ALA and its reduced form DHLA directly scavenge free radicals and regenerate vitamins C and E, coenzyme Q10, and glutathione—amplifying the entire antioxidant network.
- Glucose metabolism (GLUT4): ALA stimulates GLUT4 glucose transporter translocation to the cell surface independently of insulin, improving glucose uptake in muscle and fat cells—a key insulin-sensitising mechanism.
- AGE prevention: ALA reduces formation of advanced glycation end-products (AGEs)—the protein-sugar cross-links that damage nerves, blood vessels, and kidneys in diabetes.
- Nrf2 activation: ALA activates the Nrf2 pathway, upregulating endogenous antioxidant enzymes (glutathione synthase, thioredoxin reductase, heme oxygenase-1).
India has 101 million diagnosed diabetics (IDF 2021) with tens of millions more undiagnosed. Diabetic peripheral neuropathy affects 25–50% of long-duration diabetics and causes significant pain, disability, and foot ulceration risk. Alpha-lipoic acid 600mg/day is the most evidence-backed supplement for this condition, with the ALADIN, SYDNEY, and SYDNEY 2 trials all showing significant symptom reduction (pain, burning, paresthesias, numbness). ALA is available in India as a prescription medication (Thioctacid) and as a supplement.
R-ALA vs Racemic vs R-Na-ALA
| Form | Bioavailability | Stability | Best For |
|---|---|---|---|
| R-ALA (free acid) | High | Low (heat sensitive) | General supplementation; requires careful storage |
| Racemic ALA | Moderate (50% active) | Better than R-ALA | Budget option; still effective at higher doses |
| R-Na-ALA (sodium salt) | Very high | Excellent | Best overall; most bioavailable oral form |
| Thioctacid (prescription IV) | 100% (intravenous) | N/A | Acute diabetic neuropathy; hospital use |
ALA has meaningful blood sugar-lowering effects via GLUT4 activation. Diabetics taking ALA alongside metformin, sulfonylureas, or insulin should monitor blood glucose closely—hypoglycaemia is possible. Discuss with your diabetologist before starting ALA if you are on glucose-lowering medications. Non-diabetics with normal blood sugar generally experience no hypoglycaemia at standard doses.
Frequently Asked Questions
R-ALA vs standard alpha lipoic acid – what's the difference?
R-ALA is 2–4× more bioavailable than racemic ALA and is the natural mitochondrially-produced form. The S-isomer may compete with R-ALA for cell uptake. R-Na-ALA (sodium salt) is the most stable and bioavailable oral form. For general antioxidant use: R-ALA or R-Na-ALA at 300mg/day. For neuropathy: 600mg/day. Racemic ALA works at higher doses (600–1200mg) but is less efficient.
Is ALA effective for diabetic neuropathy in India?
Yes—ALA has the strongest supplement evidence for diabetic peripheral neuropathy. ALADIN trials (European multicentre): IV 600mg/day significantly reduced neuropathy symptoms. SYDNEY 2 trial: oral 600mg/day reduced total symptom score (pain, burning, tingling, numbness) vs placebo. With 25–50% of long-duration Indian diabetics developing neuropathy, ALA is among the most important supplements for this population. Available as Thioctacid (prescription) or as supplements.
What is the correct ALA dose?
For general antioxidant/longevity: 300mg R-ALA or R-Na-ALA on empty stomach. For diabetic neuropathy: 600mg/day (300mg twice daily or 600mg once). For blood sugar support: 600–1200mg racemic ALA or 300–600mg R-ALA. Always take on empty stomach—food reduces absorption by 30–40%. Space away from iron and mineral supplements by 2+ hours.
Does ALA lower blood sugar?
Yes. ALA activates GLUT4 translocation (insulin-independent glucose uptake), reducing fasting glucose and improving insulin sensitivity. RCTs show ALA reduces HbA1c by 0.3–0.5% and fasting glucose by 5–10 mg/dL in T2D. Diabetics on glucose-lowering drugs must monitor closely—combination can cause hypoglycaemia. Non-diabetics at standard doses (300–600mg) rarely experience problematic blood sugar drops.